Cargando…
Sex Differences in Tolerance to Delta-9-Tetrahydrocannabinol in Mice With Cisplatin-Evoked Chronic Neuropathic Pain
Tolerance to the pain-relieving effects of cannabinoids limits the therapeutic potential of these drugs in patients with chronic pain. Recent preclinical research with rodents and clinical studies in humans has suggested important differences between males and females in the development of tolerance...
Autores principales: | Henderson-Redmond, Angela N., Crawford, LaTaijah C., Sepulveda, Diana E., Hale, David E., Lesperance, Julia J., Morgan, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267820/ https://www.ncbi.nlm.nih.gov/pubmed/34250019 http://dx.doi.org/10.3389/fmolb.2021.684115 |
Ejemplares similares
-
Decursinol-mediated antinociception and anti-allodynia in acute and neuropathic pain models in male mice: Tolerance and receptor profiling
por: Crawford, LaTaijah C., et al.
Publicado: (2022) -
Sex differences in acute delta-9-tetrahydrocannabinol (Δ(9)-THC) response and tolerance as a function of mouse strain
por: Lulek, Courtney F., et al.
Publicado: (2023) -
The Role of Tumour Metabolism in Cisplatin Resistance
por: Wang, Lude, et al.
Publicado: (2021) -
microRNA-Based Network and Pathway Analysis for Neuropathic Pain in Rodent Models
por: Zheng, Yi-Li, et al.
Publicado: (2022) -
Combinations of Cannabidiol and Δ(9)-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
por: Sepulveda, Diana E., et al.
Publicado: (2022)